Related Experiment Video
Updated: Jun 25, 2026
07:49
Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Mitochondrial genome alterations in rectal and sigmoid carcinomas
Manuela Pinheiro1, Isabel Veiga, Carla Pinto
1Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
Cancer Letters
|March 10, 2009
Summary
Mitochondrial DNA alterations are common in both rectal and sigmoid cancers, potentially contributing to their development. These genetic changes in cancer cells offer insights into tumor pathogenesis.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Limited research exists on molecular pathways in rectal cancer pathogenesis.
- Mitochondrial DNA alterations are implicated in various human cancers.
- Rectal and colon cancer pathways may differ significantly.
Purpose of the Study:
- To investigate mitochondrial DNA microsatellite sequence alterations (D310, ND1, ND5) in rectal and sigmoid carcinomas.
- To assess nuclear microsatellite instability in these cancer types.
- To compare molecular findings between rectal and sigmoid cancers.
Main Methods:
- Analysis of D310, ND1, and ND5 microsatellite sequences in 38 rectal and 25 sigmoid carcinomas.
- Evaluation of nuclear microsatellite instability.
- Comparative analysis of molecular alterations.
Main Results:
- D310 sequence alterations found in 34.3% of rectal and 37.5% of sigmoid carcinomas.
- ND1 mutations detected in 2.6% of rectal carcinomas.
- ND5 mutations found in 5.3% of rectal and 8% of sigmoid carcinomas.
- A trend towards nuclear-mitochondrial instability association in sigmoid but not rectal cancers.
Conclusions:
- Mitochondrial genome alterations are prevalent in both rectal and sigmoid carcinomas.
- These alterations may play a role in the pathogenesis of these cancers.
- Further research is needed to elucidate the specific mechanisms.
